Correlation Between Sartorius Stedim and ConvaTec Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and ConvaTec Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and ConvaTec Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and ConvaTec Group Plc, you can compare the effects of market volatilities on Sartorius Stedim and ConvaTec Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of ConvaTec Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and ConvaTec Group.

Diversification Opportunities for Sartorius Stedim and ConvaTec Group

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sartorius and ConvaTec is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and ConvaTec Group Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ConvaTec Group Plc and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with ConvaTec Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ConvaTec Group Plc has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and ConvaTec Group go up and down completely randomly.

Pair Corralation between Sartorius Stedim and ConvaTec Group

Assuming the 90 days horizon Sartorius Stedim Biotech is expected to under-perform the ConvaTec Group. But the pink sheet apears to be less risky and, when comparing its historical volatility, Sartorius Stedim Biotech is 3.44 times less risky than ConvaTec Group. The pink sheet trades about -0.32 of its potential returns per unit of risk. The ConvaTec Group Plc is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  271.00  in ConvaTec Group Plc on September 1, 2024 and sell it today you would earn a total of  24.00  from holding ConvaTec Group Plc or generate 8.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  ConvaTec Group Plc

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
ConvaTec Group Plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ConvaTec Group Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, ConvaTec Group is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Sartorius Stedim and ConvaTec Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and ConvaTec Group

The main advantage of trading using opposite Sartorius Stedim and ConvaTec Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, ConvaTec Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ConvaTec Group will offset losses from the drop in ConvaTec Group's long position.
The idea behind Sartorius Stedim Biotech and ConvaTec Group Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges